Thomas Finne's most recent trade in Anika Therapeutics Inc. was a trade of 2,548 Common Stock done . Disclosure was reported to the exchange on March 9, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 2,548 | 25,346 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 2,548 | 5,097 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.22 per share. | 09 Mar 2022 | 748 | 24,598 (0%) | 0% | 26.2 | 19,613 | Common Stock |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,000 | 0 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,000 | 23,679 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 2,834 | 21,511 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 2,834 | 2,833 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.13 per share. | 25 Feb 2022 | 881 | 22,798 (0%) | 0% | 32.1 | 28,307 | Common Stock |
| Anika Therapeutics Inc | Thomas Finnerty | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.13 per share. | 25 Feb 2022 | 832 | 20,679 (0%) | 0% | 32.1 | 26,732 | Common Stock |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,638 | 62,531 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 1,515 | 60,893 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 1,593 | 59,378 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Sale of securities on an exchange or to another person at price $ 14.99 per share. | 27 May 2021 | 5,000 | 57,785 (0%) | 0% | 15.0 | 74,965 | Common Shares |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 1,693 | 62,785 (0%) | 0% | 0 | Common Shares |